Navigation Links
Alere Announces Preliminary Results Of Voting At Annual Meeting
Date:8/7/2013

WALTHAM, Mass., Aug. 7, 2013 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company" or "Alere") today announced that, based on a preliminary count of votes cast at the Company's 2013 Annual Meeting of Stockholders held today, stockholders have elected all four of the Company's director nominees, Hakan Bjorklund, Stephen MacMillan, Brian Markison and Sir Thomas McKillop.

Alere issued the following statement:

"Alere's Board and management team appreciate the feedback we have received from our stockholders, and we extend our gratitude for their support of our independent director nominees. Our plan to improve organic revenue growth, drive higher operating margins and reduce leverage has been recognized. While we are pleased with our progress to date, this process has only further sharpened our commitment to delivering strong results.

"We look forward to benefitting from the unique operational experience and fresh perspectives of our new board members and building on our positive momentum as we continue to work to enhance stockholder value. We also look forward to our Board acting on the recommendation to appoint Gregg Powers, who our nominating committee believes can help guide our strategy and serve as another independent voice for stockholders on the Board."

The preliminary voting also indicated that stockholders approved all of the other proposals submitted for a vote at the Annual Meeting.

The meeting was adjourned to 12:30 p.m. on August 19, 2013 at The Emerging Enterprise Center at Foley Hoag LLP located at 1000 Winter Street, Suite 4000, Waltham, Massachusetts 02451, solely to receive the final report of IVS Associates, Inc., the independent inspector of elections. 

About Alere

By developing new capabilities in near-patient diagnosis, monitoring and health information technology, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes.  Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere please visit www.alere.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the outcome of the vote on each matter. These statements reflect our current views with respect to future events and are based on management's current assumptions and information currently available. Actual results may differ materially due to numerous factors including, without limitation, the independent inspector's final tabulation of voting results. We undertake no obligation to update any forward-looking statements contained herein.


'/>"/>
SOURCE Alere Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere Inc. Schedules Conference Call for 8:30 a.m. ET July 31, 2013 to Discuss Second Quarter 2013 Results
2. Alere Accountable Care Solutions to Provide Health Information Network to Childrens Care Alliance for Underserved Children
3. Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
4. Alere Inc. Announces Tender Offer and Consent Solicitation for Any and All of its 9.00% Senior Subordinated Notes due 2016
5. Alere Acquires Epocal, Inc.
6. Alere Inc. Announces Hiring of Namal Nawana as Chief Operating Officer
7. Alere Inc. Announces Early Results of its Tender Offer and Consent Solicitation for Any and All of its 7.875% Senior Notes due 2016
8. Alere Inc. Announces Offering of $450 Million of Senior Notes
9. Heska Announces Financial Results for the Second Quarter of Fiscal 2013
10. Ohr Pharmaceutical Announces Addition of Dr. John Wroblewski to Ophthalmic Scientific Advisory Board
11. FullCircle Registry, Inc. Announces Letter of Intent to Purchase Medical Supply Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... communities in the greater Dallas, Miami, and Raleigh regions, is organizing an extended ... overcome a rare and deadly chromosome abnormality. , After struggling since birth with ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):